Citation Impact
Citing Papers
Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
2005 Standout
The efficacy and value of emergency medicine: a supportive literature review
2011 Standout
Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
The role of nebulised budesonide in the treatment of exacerbations of COPD
2007
Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease<subtitle>A Disease-Specific Self-management Intervention</subtitle>
2003 Standout
ED utilization: The effect of changing demographics from 1992 to 2000
2002
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Oral or IV Prednisolone in the Treatment of COPD Exacerbations
2007
In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation
2001
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
2003
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
New treatments for copd
2002
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2009
Chronic obstructive pulmonary disease
2003
Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation
2005
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
COPD exacerbations {middle dot} 5: Management
2006
Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
2005
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
2002 Standout
Contemporary Management of Acute Exacerbations of COPD
2008
COPD exacerbations: defining their cause and prevention
2007
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
2006 Standout
Impact of preventing exacerbations on deterioration of health status in COPD
2004 Standout
Association of Corticosteroid Dose and Route of Administration With Risk of Treatment Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
2010
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
2009
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
2007
Chronic Obstructive Pulmonary Disease
2000
Development and first validation of the COPD Assessment Test
2009 Standout
The global burden of multiple chronic conditions: A narrative review
2018 Standout
Interpretative strategies for lung function tests
2005 Standout
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
2003
Longitudinal changes in the nature, severity and frequency of COPD exacerbations
2003
Anti-Inflammatory Effects of Combined Budesonide/Formoterol in COPD Exacerbations
2008
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
2003
State of Telehealth
2016 Standout
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Exacerbations of chronic obstructive pulmonary disease
2007
Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2013
Comparison of two systemic steroid regimens for the treatment of COPD exacerbations
2013
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2002
Systemic Glucocorticoids in Severe Exacerbations of COPD
2001
Airway Mucus Function and Dysfunction
2010 Standout
Drug discovery from medicinal plants
2005 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease
2004
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
2014
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
Impact of Exacerbations on Emphysema Progression in Chronic Obstructive Pulmonary Disease
2011
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
2003
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
2003
The Future History of Home Care and Physician House Calls in the United States
2001
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Effects of an integrated care intervention on risk factors of COPD readmission
2007
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model
2015 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
2000
Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease
2012
Comparison of Nebulized Budesonide and Oral Prednisolone with Placebo in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2002
American Thoracic Society Statement
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease
2004
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
2010
Physical Activity and Public Health in Older Adults
2007 Standout
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
Methodological issues in evaluating measures of health as outcomes for COPD
2003
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of RM Angus being referenced
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial
1999